Send your comments and tips to firstname.lastname@example.org
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Thursday, September 27, 2007
Today's Globe: vaccine mercury, 'good' cholesterol, veterans care, DSS plan, MS drug, melanoma drug, Dr. Gherardo Gherardi
A mercury-based preservative once used in many vaccines does not raise the risk of neurological problems in children, concludes a large federal study that researchers say should reassure parents about the safety of shots their children received a decade or more ago. The study, however, did not examine autism - the developmental disorder that some critics blame on vaccines. A separate study due out in a year will look at that issue.
The amount of "good cholesterol" in the blood remains an important marker for heart disease regardless of how much "bad cholesterol" is lowered, researchers said yesterday.
A bill that would reconfigure the leadership of the Department of Social Services was criticized yesterday by union officials, who said the focus of improving child-protection efforts should be at the ground level, where they said social worker caseloads need to be reduced.
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis.
A very early test of an experimental drug seemed to slow the spread of advanced melanoma in a small study, Synta Pharmaceuticals Corp. of Lexington reported in preliminary findings yesterday.
Dr. Gherardo "Zeke" Gherardi (left) of Wellesley, who taught pathology at Tufts Medical School, Boston-Bouve School of Physical Therapy at Northeastern and Boston University School of Medicine and was an associate pathologist at Framingham Union Hospital, died Sept. 6 in an automobile accident near Hearne, Texas, while visiting. He was 86.